Niacin (B3) and Niacin (B3) for Pellagra
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Niacin (B3)
Corrects pellagra, powerfully shifts blood lipids — but as a heart drug it failed to cut events and added harm.
Grade B4 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Niacin (B3) for Pellagra
Evidence grade A — Definitional
Grade A1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Niacin (B3) | Niacin (B3) for Pellagra |
|---|---|---|
| Pellagra | Evidence grade ALarge effecthighDefinitional | Evidence grade ALarge effecthighDefinitional |
Graded only in Niacin (B3)
- HDL / triglycerides Large effectEvidence grade A
- Cardiovascular events Trivial effectEvidence grade D
- Non-melanoma skin cancer (nicotinamide) Small effectEvidence grade B
Graded only in Niacin (B3) for Pellagra
None — every outcome it grades is graded in both.
What each entry says about the other
- Niacin (B3) for Pellagra’s entry · Goes with: Read the full Niacin (B3) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.